- Home
- RDY vs HCI Comparison
RDY vs HCI Comparison
Compare RDY & HCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDY
- HCI
- Stock Information
- Founded
- RDY 1984
- HCI 2006
- Country
- RDY India
- HCI United States
- Employees
- RDY N/A
- HCI N/A
- Industry
- RDY Biotechnology: Pharmaceutical Preparations
- HCI Property-Casualty Insurers
- Sector
- RDY Health Care
- HCI Finance
- Exchange
- RDY Nasdaq
- HCI Nasdaq
- Market Cap
- RDY 2.1B
- HCI 1.7B
- IPO Year
- RDY N/A
- HCI N/A
- Fundamental
- Price
- RDY $14.60
- HCI $141.12
- Analyst Decision
- RDY Strong Buy
- HCI Strong Buy
- Analyst Count
- RDY 2
- HCI 4
- Target Price
- RDY $16.95
- HCI $181.25
- AVG Volume (30 Days)
- RDY 1.4M
- HCI 171.3K
- Earning Date
- RDY 07-28-2025
- HCI 08-07-2025
- Dividend Yield
- RDY 0.56%
- HCI 1.13%
- EPS Growth
- RDY 1.47
- HCI 4.05
- EPS
- RDY 0.79
- HCI 10.46
- Revenue
- RDY $3,809,801,863.00
- HCI $759,870,000.00
- Revenue This Year
- RDY $10.24
- HCI $19.25
- Revenue Next Year
- RDY N/A
- HCI $4.08
- P/E Ratio
- RDY $18.44
- HCI $13.53
- Revenue Growth
- RDY 16.61
- HCI 20.95
- 52 Week Low
- RDY $12.26
- HCI $87.01
- 52 Week High
- RDY $16.89
- HCI $176.40
- Technical
- Relative Strength Index (RSI)
- RDY 42.74
- HCI 36.43
- Support Level
- RDY $14.46
- HCI $136.75
- Resistance Level
- RDY $15.25
- HCI $147.68
- Average True Range (ATR)
- RDY 0.18
- HCI 4.07
- MACD
- RDY -0.10
- HCI -0.49
- Stochastic Oscillator
- RDY 16.40
- HCI 28.52
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
About HCI HCI Group Inc.
HCI Group Inc is engaged in the property and casualty insurance business through two Florida domiciled insurance companies, Homeowners Choice Property & Casualty Insurance Company (HCPCI) and TypTap Insurance Company (TypTap). Both HCPCI and TypTap are authorized to underwrite various homeowners' property and casualty insurance products and allied lines business in the state of Florida and other states. The operating segments of the group are insurance operations, TypTap Group, reciprocal exchange operations, real estate operations, and corporate and other. It derives key revenue from the HCPCI Insurance operation segment.